Trial Profile
Efficacy and tolerability of two formulations of botulinum toxin A (Dysport vs Prosigne) in patients with cervical dystonia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2015
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Torticollis
- Focus Adverse reactions; Therapeutic Use
- 09 Nov 2015 New trial record
- 03 Nov 2015 Results published in Clinical Neuropharmacology